Fundraising FoxMARAbio
4 known investors
Find your way into MARAbio
Sign up to see every warm intro you have to MARAbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MARAbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MARAbio is a precision immunology company developing blood tests to identify Maternal Autoantibody Related Autism (MARA), a subtype estimated to represent up to 20% of autism diagnoses, alongside companion diagnostics and therapeutic antibody interventions for early detection and targeted treatment.
Investors · 4
AIFlisted by AIFNew York
How we know: AIF's portfolio page · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
MAK CapitalleadMAK Capital OneleadMAK Capital One, LLClead
Funding
SEC filings, press & company announcements$19M disclosed across 1 of 2 rounds · 2024
- $19Mseries AOct 2024 · 5 sources
MAK Capital (lead), MAK Capital One (lead), MAK Capital One, LLC (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does MARAbio do?
- MARAbio is a precision immunology company developing blood tests to identify Maternal Autoantibody Related Autism (MARA), a subtype estimated to represent up to 20% of autism diagnoses, alongside companion diagnostics and therapeutic antibody interventions for early detection and targeted treatment.
- Who are MARAbio's investors?
- MARAbio's investors include AIF.
- How much funding has MARAbio raised?
- MARAbio has disclosed $19M raised across 1 of its 2 known rounds.